282 related articles for article (PubMed ID: 21211030)
21. SnoN is a cell type-specific mediator of transforming growth factor-beta responses.
Sarker KP; Wilson SM; Bonni S
J Biol Chem; 2005 Apr; 280(13):13037-46. PubMed ID: 15677458
[TBL] [Abstract][Full Text] [Related]
22. Ski regulates Smads and TAZ signaling to suppress lung cancer progression.
Xie M; Wu X; Zhang J; Zhang J; Li X
Mol Carcinog; 2017 Oct; 56(10):2178-2189. PubMed ID: 28398634
[TBL] [Abstract][Full Text] [Related]
23. Loss of c-myc repression coincides with ovarian cancer resistance to transforming growth factor beta growth arrest independent of transforming growth factor beta/Smad signaling.
Baldwin RL; Tran H; Karlan BY
Cancer Res; 2003 Mar; 63(6):1413-9. PubMed ID: 12649207
[TBL] [Abstract][Full Text] [Related]
24. Transforming growth factor-beta suppresses the ability of Ski to inhibit tumor metastasis by inducing its degradation.
Le Scolan E; Zhu Q; Wang L; Bandyopadhyay A; Javelaud D; Mauviel A; Sun L; Luo K
Cancer Res; 2008 May; 68(9):3277-85. PubMed ID: 18451154
[TBL] [Abstract][Full Text] [Related]
25. Ubiquitin-dependent degradation of SnoN and Ski is increased in renal fibrosis induced by obstructive injury.
Fukasawa H; Yamamoto T; Togawa A; Ohashi N; Fujigaki Y; Oda T; Uchida C; Kitagawa K; Hattori T; Suzuki S; Kitagawa M; Hishida A
Kidney Int; 2006 May; 69(10):1733-40. PubMed ID: 16625151
[TBL] [Abstract][Full Text] [Related]
26. Downregulation of Ski and SnoN co-repressors by anisomycin.
Vázquez-Macías A; Ruíz-Mendoza AB; Fonseca-Sánchez MA; Briones-Orta MA; Macías-Silva M
FEBS Lett; 2005 Jul; 579(17):3701-6. PubMed ID: 15967445
[TBL] [Abstract][Full Text] [Related]
27. Two short segments of Smad3 are important for specific interaction of Smad3 with c-Ski and SnoN.
Mizuide M; Hara T; Furuya T; Takeda M; Kusanagi K; Inada Y; Mori M; Imamura T; Miyazawa K; Miyazono K
J Biol Chem; 2003 Jan; 278(1):531-6. PubMed ID: 12426322
[TBL] [Abstract][Full Text] [Related]
28. SnoN and Ski protooncoproteins are rapidly degraded in response to transforming growth factor beta signaling.
Sun Y; Liu X; Ng-Eaton E; Lodish HF; Weinberg RA
Proc Natl Acad Sci U S A; 1999 Oct; 96(22):12442-7. PubMed ID: 10535941
[TBL] [Abstract][Full Text] [Related]
29. The downregulation of SnoN expression in human renal proximal tubule epithelial cells under high-glucose conditions is mediated by an increase in Smurf2 expression through TGF-β1 signaling.
Li X; Diao Z; Ding J; Liu R; Wang L; Huang W; Liu W
Int J Mol Med; 2016 Feb; 37(2):415-22. PubMed ID: 26743567
[TBL] [Abstract][Full Text] [Related]
30. The oncoprotein c-ski functions as a direct antagonist of the transforming growth factor-{beta} type I receptor.
Ferrand N; Atfi A; Prunier C
Cancer Res; 2010 Nov; 70(21):8457-66. PubMed ID: 20959473
[TBL] [Abstract][Full Text] [Related]
31. Competition between Ski and CREB-binding protein for binding to Smad proteins in transforming growth factor-beta signaling.
Chen W; Lam SS; Srinath H; Schiffer CA; Royer WE; Lin K
J Biol Chem; 2007 Apr; 282(15):11365-76. PubMed ID: 17283070
[TBL] [Abstract][Full Text] [Related]
32. Downregulation of SnoN expression in obstructive nephropathy is mediated by an enhanced ubiquitin-dependent degradation.
Tan R; Zhang J; Tan X; Zhang X; Yang J; Liu Y
J Am Soc Nephrol; 2006 Oct; 17(10):2781-91. PubMed ID: 16959829
[TBL] [Abstract][Full Text] [Related]
33. Downregulation of SnoN oncoprotein induced by antibiotics anisomycin and puromycin positively regulates transforming growth factor-β signals.
Hernández-Damián J; Tecalco-Cruz AC; Ríos-López DG; Vázquez-Victorio G; Vázquez-Macías A; Caligaris C; Sosa-Garrocho M; Flores-Pérez B; Romero-Avila M; Macías-Silva M
Biochim Biophys Acta; 2013 Nov; 1830(11):5049-58. PubMed ID: 23872350
[TBL] [Abstract][Full Text] [Related]
34. c-Ski inhibits the TGF-beta signaling pathway through stabilization of inactive Smad complexes on Smad-binding elements.
Suzuki H; Yagi K; Kondo M; Kato M; Miyazono K; Miyazawa K
Oncogene; 2004 Jun; 23(29):5068-76. PubMed ID: 15107821
[TBL] [Abstract][Full Text] [Related]
35. Ski and SnoN: negative regulators of TGF-beta signaling.
Luo K
Curr Opin Genet Dev; 2004 Feb; 14(1):65-70. PubMed ID: 15108807
[TBL] [Abstract][Full Text] [Related]
36. Ski and SnoN, potent negative regulators of TGF-beta signaling.
Deheuninck J; Luo K
Cell Res; 2009 Jan; 19(1):47-57. PubMed ID: 19114989
[TBL] [Abstract][Full Text] [Related]
37. Differential role of Sloan-Kettering Institute (Ski) protein in Nodal and transforming growth factor-beta (TGF-β)-induced Smad signaling in prostate cancer cells.
Vo BT; Cody B; Cao Y; Khan SA
Carcinogenesis; 2012 Nov; 33(11):2054-64. PubMed ID: 22843506
[TBL] [Abstract][Full Text] [Related]
38. Ski prevents TGF-β-induced EMT and cell invasion by repressing SMAD-dependent signaling in non-small cell lung cancer.
Yang H; Zhan L; Yang T; Wang L; Li C; Zhao J; Lei Z; Li X; Zhang HT
Oncol Rep; 2015 Jul; 34(1):87-94. PubMed ID: 25955797
[TBL] [Abstract][Full Text] [Related]
39. Ski/Sno and TGF-beta signaling.
Liu X; Sun Y; Weinberg RA; Lodish HF
Cytokine Growth Factor Rev; 2001 Mar; 12(1):1-8. PubMed ID: 11312113
[TBL] [Abstract][Full Text] [Related]
40. Smad3 recruits the anaphase-promoting complex for ubiquitination and degradation of SnoN.
Stroschein SL; Bonni S; Wrana JL; Luo K
Genes Dev; 2001 Nov; 15(21):2822-36. PubMed ID: 11691834
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
